Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study (Q33403106)

26 July 2017

title

Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study (English)

1 reference

26 July 2017

main subject

hepatocellular carcinoma

1 reference

Edoardo G Giannini

11

0 references

author name string

Fabio Farinati

1

1 reference

26 July 2017

Adriana Sergio

2

1 reference

26 July 2017

Anna Baldan

3

1 reference

26 July 2017

Anna Giacomin

4

1 reference

26 July 2017

Maria Anna Di Nolfo

5

1 reference

26 July 2017

Paolo Del Poggio

6

1 reference

26 July 2017

Luisa Benvegnu

7

1 reference

26 July 2017

Gianludovico Rapaccini

8

1 reference

26 July 2017

Marco Zoli

9

1 reference

26 July 2017

Franco Borzio

10

1 reference

26 July 2017

Eugenio Caturelli

12

1 reference

26 July 2017

Franco Trevisani

13

1 reference

26 July 2017

language of work or name

English

0 references

publication date

27 January 2009

1 reference

26 July 2017

1 reference

26 July 2017

volume

9

1 reference

26 July 2017

page(s)

33

1 reference

Creative Commons Attribution 2.0 Generic

26 July 2017

copyright license

start time

27 January 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Novel advancements in the management of hepatocellular carcinoma in 2008.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640412

Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640412

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640412

Management of hepatocellular carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640412

Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640412

Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640412

Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640412

Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640412

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640412

Prognosis of hepatocellular carcinoma: the BCLC staging classification

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640412

Transection of the oesophagus for bleeding oesophageal varices

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640412

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640412

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-33

Prospective validation of the Barcelona Clinic Liver Cancer staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-33

Critical evaluation of the different staging systems for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-33

Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-33

The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-33

Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-33

Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2640412

The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?

31 October 2018

1 reference

12 December 2020

Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery

1 reference

12 December 2020

Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan

1 reference

12 December 2020

Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients

1 reference

12 December 2020

Ethanol versus radiofrequency ablation for the treatment of small hepatocellular carcinoma in patients with cirrhosis: a retrospective study of efficacy and cost

1 reference

12 December 2020

1 reference

12 December 2020

Simplified staging for hepatocellular carcinoma

1 reference

12 December 2020

Staging systems for hepatocellular carcinoma: should we all use the BCLC system?

1 reference

12 December 2020

How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system

1 reference

12 December 2020

A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-9-33

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference